ACCESS Newswire

    / Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (“LOI”) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.

    / PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s

    Latest News

    – The UAE recorded $63.353 billion in outward foreign direct investment during 2025, according to UN Trade and Development. The country’s total outward FDI stock reached $402.729 billion at the end of the year. That figure stood at $55.560 billion